MindMed's LSD trials are facing a regulatory roadblock but MNMD stock isn't being forced down. Here's why investors should watch. More
Articles
Lucid Group Got a Credibility Boost From Its Prestigious Index Inclusion
LCID stock may be worth catching at a reduced price as a prominent Wall Street expert sees the wisdom in its approach to raising cash. More
CCL Stock Alert: 16 Reasons Why Carnival Is Cruising Higher Today
Carnival (CCL) stock is sailing higher on Tuesday and there are several reasons why that investors need to know about that rise. More
#ShibaArmy Unites After Ask the Doctor Reverses Course on the SHIB Crypto
The #ShibaArmy is gathering in support of the pupcoin today after medical news outlet Ask the Doctor takes aim at the token. More
Nokia’s Long-Term Growth Prospects Are Primarily Tied to 5G+
Nokia investors should know that the 5G+ technology that will drive NOK stock growth is not the same 5G+ your cell provider is trying to sell you. More
CTXS Stock: 6 Things to Know About the Joint Bid for Citrix Systems
Shares of CTXS stock are flying higher after news of a potential joint bid by Elliott Management and Vista Equity Partners. More
Desktop Metal Stock Will Keep Dropping Like a 3D-Printed Lead Balloon
There is little to suggest Desktop Metal's horrendous operating performance will improve any time soon. Steer clear of DM stock. More
